Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biomarin Pharmaceut (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,735,859
  • Shares Outstanding, K 178,062
  • Annual Sales, $ 1,314 M
  • Annual Income, $ -117,040 K
  • 36-Month Beta 1.63
  • Price/Sales 11.08
  • Price/Cash Flow N/A
  • Price/Book 5.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.09
  • Number of Estimates 7
  • High Estimate 0.15
  • Low Estimate -0.26
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
91.50 +0.46%
on 01/28/19
100.13 -8.19%
on 02/05/19
-5.76 (-5.90%)
since 01/18/19
3-Month
79.13 +16.17%
on 12/26/18
100.13 -8.19%
on 02/05/19
-1.78 (-1.90%)
since 11/19/18
52-Week
75.81 +21.26%
on 04/06/18
106.74 -13.88%
on 10/17/18
+6.94 (+8.17%)
since 02/16/18

Most Recent Stories

More News
Market Trends Toward New Normal in Brighthouse Financial, BioMarin Pharmaceutical, EZCORP, Assembly Biosciences, A-Mark Precious Metals, and American Public Education -- Emerging Consolidated Expectations, Analyst Ratings

EQNX::TICKER_START (:BHF),(:BMRN),(:EZPW),(:ASMB),(:AMRK),(:APEI), EQNX::TICKER_END

BHF : 42.76 (+1.93%)
BMRN : 91.86 (-2.27%)
ASMB : 22.47 (-1.79%)
AMRK : 12.74 (+0.39%)
BHFWV : 64.57 (+0.89%)
EZPW : 10.14 (+1.20%)
APEI : 31.44 (-0.95%)
BioMarin Announces 14 Presentations at 15th Annual WORLDSymposium(TM) 2019

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company will present data in four platform and 10 poster presentations at the 15th Annual WORLDSymposiumTM being held February 4-8,...

BMRN : 91.86 (-2.27%)
BioMarin to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 21 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February...

BMRN : 91.86 (-2.27%)
BioMarin Highlights Key Milestones for 2019 at 37th Annual J.P. Morgan Healthcare Conference in San Francisco

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a company focused on innovative therapies to treat rare diseases, provided highlights to the investment community on its key milestones for 2019 at the 37th...

JPM : 105.21 (-0.32%)
BMRN : 91.86 (-2.27%)
BioMarin to Present at 37th Annual J.P. Morgan Healthcare Conference in San Francisco

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 37th Annual J.P. Morgan Healthcare Conference on Monday,...

JPM : 105.21 (-0.32%)
BMRN : 91.86 (-2.27%)
5 Top Drug/Biotech Merger & Acquisition Targets for 2019

Here are five stocks that are attractive and most likely to be takeout targets in 2019.

CELG : 90.70 (+0.01%)
BMRN : 91.86 (-2.27%)
VRTX : 186.82 (-0.66%)
ALNY : 80.39 (-3.76%)
INCY : 84.03 (-0.14%)
SNY : 42.21 (-0.80%)
ALXN : 128.91 (-0.39%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 23.30 (-0.34%)
NGVC : 14.84 (-1.53%)
STC : 42.76 (+0.09%)
ATUS : 21.44 (-0.69%)
RBA : 36.49 (-0.41%)
MHK : 139.73 (+0.37%)
NVCR : 53.02 (-0.32%)
CVSI : 4.7500 (-3.26%)
AC : 41.81 (-0.76%)
BSX : 39.86 (-0.37%)
HON : 153.28 (-0.03%)
POTND : 0.0200 (+32.45%)
PRTT : 1.0000 (-20.00%)
TARSD : 0.2033 (-1.64%)
NKE : 84.56 (-0.96%)
ROIC : 17.79 (-0.17%)
DGX : 88.06 (+0.28%)
EIX : 61.64 (+1.88%)
GARLF : 0.0820 (-2.61%)
MRNA : 20.82 (-2.89%)
MSPC : 0.0001 (-50.00%)
RYAAY : 73.60 (+1.77%)
BA : 416.37 (-0.38%)
BDC : 56.55 (-0.16%)
BC : 51.91 (+0.93%)
OXFD : 16.75 (-0.83%)
NDAQ : 87.81 (+0.06%)
TTOO : 3.73 (+1.08%)
DMAC : 3.45 (+9.18%)
CMCM : 7.31 (+3.25%)
ALGN : 255.22 (+0.10%)
ABM : 36.33 (+0.36%)
RTN : 184.66 (+0.03%)
IESC : 18.70 (+0.48%)
KIDS : 37.38 (+0.92%)
CYL.VN : 0.155 (unch)
FLIR : 52.04 (-0.71%)
NETC.CN : 0.105 (+5.00%)
SLCA : 15.24 (+5.54%)
BANX : 20.90 (-1.65%)
APOG : 36.36 (+0.25%)
RBBN : 6.13 (+5.33%)
SPLIF : 0.2173 (-2.03%)
SO : 48.91 (+0.72%)
SNWV : 0.1885 (-0.79%)
ACB : 6.93 (-1.70%)
CE : 100.93 (+0.67%)
QILFF : 0.1850 (+1.04%)
QILFD : 0.2331 (-29.98%)
MANH : 54.53 (+0.55%)
MKL : 1,017.18 (+0.73%)
HAL : 31.70 (-0.47%)
LZB : 32.23 (+2.61%)
INTC : 51.40 (-0.50%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,627.39 (+1.21%)
ACHC : 28.08 (-1.16%)
TX : 31.40 (+0.25%)
SRPT : 140.35 (+1.37%)
JOUT : 65.98 (-0.09%)
CCAN : 0.2448 (+2.00%)
OBMP : 0.0091 (-3.19%)
ELY : 16.74 (+1.58%)
DY : 62.90 (-0.35%)
HIPH : 0.0526 (-2.59%)
POTN : 0.1744 (+9.69%)
JWN : 45.25 (+1.82%)
SYF : 31.76 (+0.03%)
AQUA : 13.07 (+1.32%)
NWVCF : 1.2878 (+2.21%)
USYNF : 3.1500 (+5.77%)
EMR : 67.88 (-0.63%)
BXE : 0.46 (-3.16%)
HSY : 109.68 (+0.30%)
EW : 176.99 (-0.44%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 14.47 (-0.41%)
PSX : 96.74 (+0.78%)
MVIS : 1.12 (+2.75%)
PCI : 22.90 (+0.48%)
PCN : 16.34 (+0.25%)
AVT : 44.17 (+0.11%)
MGNX : 22.14 (+1.37%)
ICBK : 18.76 (+1.52%)
DLR : 116.45 (+1.23%)
RHI : 67.46 (+0.72%)
YVR : 2.08 (-1.42%)
PTY : 16.72 (-0.06%)
PDI : 31.20 (-0.16%)
TNXP : 1.91 (-1.55%)
GBT : 50.72 (-2.67%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 84.97 (+0.27%)
NKTR : 42.81 (+2.69%)
GOOG : 1,118.67 (+0.45%)
JBLU : 17.92 (-0.22%)
IGC : 2.49 (unch)
WBT : 15.85 (+4.07%)
WRY.VN : 0.100 (+66.67%)
SAPIF : 31.1174 (+0.61%)
WSO : 144.53 (+0.82%)
LMT : 305.05 (-0.71%)
CMCSA : 37.56 (-0.56%)
HSDT : 7.49 (-2.35%)
GWRE : 92.68 (-0.25%)
CLGX : 39.75 (+0.03%)
FNSR : 23.66 (+1.20%)
SONS : 7.83 (+2.76%)
DEWM : 0.0011 (-8.33%)
SLG : 92.10 (+0.55%)
UPS : 110.74 (-0.12%)
PFN : 10.25 (+0.20%)
KMB : 119.55 (+0.94%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.08 (-0.92%)
NSU : 4.53 (+0.44%)
CBDS : 3.3400 (-3.33%)
CTXS : 106.28 (-0.20%)
PCOM : 10.89 (+0.09%)
HTHT : 33.48 (+1.64%)
MAN : 84.60 (+0.20%)
CNK : 36.76 (-1.47%)
AMAT : 39.29 (+0.49%)
FMCC : 2.6200 (+1.95%)
MRK : 79.26 (-0.69%)
ATOS : 1.52 (+0.66%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0736 (+19.09%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 57.02 (-0.37%)
COOL : 17.33 (-0.69%)
SAVE : 62.34 (+1.09%)
PCRX : 39.92 (-1.87%)
RNLSY : 13.3100 (-1.11%)
COL : 141.04 (-0.42%)
COR : 104.80 (+2.02%)
IDXG : 0.94 (+1.08%)
MCD : 179.16 (-0.45%)
ETST : 0.7000 (-2.78%)
QNIIF : 0.7100 (-2.62%)
PII : 86.75 (-0.03%)
AMRS : 4.54 (-8.47%)
SON : 59.95 (+1.77%)
MCK : 136.27 (+0.52%)
APHA : 9.69 (+0.94%)
MCO : 167.85 (-0.83%)
GSKY : 10.47 (+0.38%)
LH : 149.83 (-0.23%)
SAP.TO : 42.05 (+1.01%)
ODFL : 149.56 (+2.18%)
NEU : 430.82 (-0.01%)
ORTX : 16.32 (+7.02%)
BXE.TO : 0.65 (-1.52%)
GWPRF : 12.8000 (+0.08%)
PZN : 8.99 (+0.45%)
RBX.VN : 0.080 (+6.67%)
RNG : 104.01 (-0.63%)
SPG : 182.21 (-0.63%)
TRVN : 1.50 (-2.60%)
AMC : 13.19 (-4.35%)
UTX : 128.65 (+0.70%)
AMD : 23.95 (+1.14%)
NDLS : 7.31 (-2.66%)
MPWR : 136.34 (-1.55%)
KGKG : 0.0750 (-5.06%)
FRO-UN.VN : 0.550 (+1.85%)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 24.42 (-0.73%)
IQST : 1.2500 (-15.54%)
ASPS : 25.32 (+0.52%)
HMNY : 0.0070 (-2.78%)
ROP : 311.22 (-0.24%)
GOVB : 14.0500 (-10.79%)
PKO : 26.18 (+0.11%)
MYGN : 31.50 (+0.13%)
CRL : 141.13 (+0.19%)
GLPH : 0.0175 (+15.89%)
BXXRF : 0.0102 (+100.00%)
ADTN : 14.55 (-0.95%)
GRNH : 0.0190 (-4.04%)
NS : 26.86 (+1.44%)
LTS : 3.04 (+3.05%)
INT : 26.18 (+1.71%)
INPX : 1.52 (+1.33%)
GSPT : 0.0400 (unch)
MRO.VN : 0.095 (+11.76%)
COST : 218.13 (+0.77%)
EFX : 109.33 (+0.02%)
BMRN : 91.86 (-2.27%)
SPGI : 197.71 (-0.31%)
IGCC : 0.3710 (-1.07%)
PYPL : 95.03 (+0.13%)
LHSIF : 0.8346 (+0.55%)
TDY : 235.56 (-0.35%)
AZPN : 99.72 (-0.32%)
ENW.VN : 1.700 (+2.41%)
DMA.VN : 4.630 (-2.11%)
SNAP : 9.28 (+1.75%)
KSU : 109.54 (+1.86%)
MERC : 14.78 (-1.34%)
DVA : 59.13 (+0.05%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.44 (+0.41%)
IGAP : 0.4900 (-19.67%)
FIT : 6.37 (-0.62%)
RAD : 0.78 (-2.50%)
LDSR : 0.0024 (unch)
CYLYF : 0.1149 (+8.29%)
PMX : 11.84 (+1.63%)
ROBXF : 0.1851 (+262.94%)
BRO : 29.12 (+0.21%)
Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger

Shire's (SHPG) pending acquisition by Takeda Pharmaceuticals for $62 billion gets approval from shareholders of both the companies.

AGN : 137.93 (-0.82%)
BMRN : 91.86 (-2.27%)
INCY : 84.03 (-0.14%)
SHPG : 179.20 (+4.10%)
BioMarin Promotes Amy Wireman to Group Vice President, Human Resources

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Amy Wireman to Group Vice President, Human Resources. Ms. Wireman's promotion to lead the Human Resources function globally...

BMRN : 91.86 (-2.27%)
BioMarin to Participate in Citi's 13th Annual Biotech Conference on December 5 in New York City

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in Citi's 13th Annual Biotech Conference on December 5 in New York City. To access the live webcast, please...

BMRN : 91.86 (-2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 95.32
1st Resistance Point 94.65
Last Price 91.86
1st Support Level 93.27
2nd Support Level 92.55

See More

52-Week High 106.74
Fibonacci 61.8% 94.92
Last Price 91.86
Fibonacci 50% 91.27
Fibonacci 38.2% 87.63
52-Week Low 75.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar